THE MEDICAL NEWS

EpilepsyGTx, a biotechnology company developing cutting-edge gene therapies to treat refractory epilepsy, and ClearPoint Neuro ("ClearPoint"), a global therapy-enabling company offering precise navigation and delivery to the brain, today announced a partnership to support the targeted delivery of EpilepsyGTx's lead gene therapy candidate, EPY201, for focal refractory epilepsy (FRE).

This research assesses data provenance in widely used health datasets, revealing flaws that could undermine clinical prediction models and patient care.

The study shows semaglutide's cardiovascular benefits are more closely tied to attained dose than weight loss, challenging existing treatment assumptions.

Evaxion A/S (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, presents new data further supporting the multi-component concept of its cytomegalovirus (CMV) vaccine program EVX-V1.

http://click.agilitypr.delivery/ls/click?upn=u001.Tc7zVj18oed-2F4uPsROK8aAbfeBahNf4wJ8s-2B8sMHqZWlEMd4h1Sy-2BVY7efcyzp0SSp9ahYr1EYI961foGMI00g-3D-3DIFTS_pIbxPfpDI69aAybPrpOfg0m1W6EzqVs-2FmHUNkXZ2e6j0vHkwSAXmnZeE-2FQommlLLwzsQqlRVkMJiMrz424piBBRT-2Fl4JRA42irLftTP4-2BNo-2Bd3OoK5qZ1km0Y7zpf3Y6U1R4brw1FQfk2dP9SvR-2B5Q9WS-2B5kYgdBFGO6Cp64KoEGS08qwKU3-2BLebJZNhRNQhJ0vijfSASstkVMufip2Cj0PwGsD6flTj2e2H-2…

Evonik is making a significant investment to strengthen manufacturing capabilities at its Lafayette (Tippecanoe), Indiana facility.

Researchers detected Usutu virus RNA in nine of 818 wild carnivores sampled across the Netherlands, while no animals tested positive for West Nile virus RNA. Neutralizing antibodies to one or both viruses in red foxes and stone martens indicate broader spillover exposure and suggest these species may support arbovirus surveillance.

Four weeks of a 10-minute evening cosmetic routine with self-massage improved self-reported sleep quality, state anxiety, mental health, and vitality in women with sleep complaints compared with usual routines. Exploratory wearable data showed longer total and deep sleep on rest days, but the non-randomized design and absence of wearable controls limit causal conclusions.

Whether you are an early bird or a night owl, your sleep patterns can tell a lot about a person's eating habits and subsequently the potential health risks.

A major new international study led by Curtin University, has found diabetes risk is about more than just body weight or obesity, revealing muscle health also likely plays a big role in whether people will develop the condition.